University of Baghdad
uobaghdad.edu.iqTotal trials
156
Active
51
Phase 3
11
Total enrollment
10,832
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 16 of 16 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Chlorzoxazone | — | — | — | — | — | 1 | |
| Orphenadrine Citrate | — | — | — | — | — | 1 | |
| Non surgical root surface debridement in one stage with receiving Ibuprofen | — | — | — | — | — | 1 | |
| systemic proteolytic enzyme | — | — | — | — | — | 1 | |
| Amoxicillin 500mg+metronidazole 500mg+ doliprane 100mg | — | — | — | — | — | 1 | |
| Resveratrol-Based Mouthwash | — | — | — | — | — | 1 | |
| Chlorhexidine Gluconate 0.12 % Mouthwash | — | — | — | — | — | 1 | |
| Acetaminophen | — | — | — | — | — | 1 | |
| Local melatonin powder | — | — | — | — | — | 1 | |
| Suprachoroidal triamcinolone acetonide | — | — | — | — | — | 1 | |
| Chlorohexidine 0.12% mouthwash | — | — | — | — | — | 1 | |
| Cetylpyridinium chloride 0.05% mouthwash | — | — | — | — | — | 1 | |
| Essential Oil mouthwash | — | — | — | — | — | 1 | |
| Mirror Therapy plus Soft Robotic Glove | — | — | — | — | — | 1 | |
| Metformin gel, 1% | — | — | — | — | — | 1 | |
| Microneedling + Injectable Hyaluronic Acid | — | — | — | — | — | 1 |
Next readouts
- 2024-09-01
- 2025-06-01
- 2025-08-01
- 2025-09-30
- 2026-04
- 2026-05
- 2026-06
- 2026-07-01
- 2026-09
- 2026-09-17
Top conditions
- Periodontitis13
- Periodontal Diseases8
- Orthodontic Appliance Complication6
- Plaque Induced Gingivitis4
- Impacted Third Molar Tooth4
- Root Resorption3
- Gingivitis3
- Dental Implant3
Frequently asked questions about University of Baghdad
- How many clinical trials does University of Baghdad have on ClinicalTrials.gov?
- University of Baghdad is listed as the lead sponsor on 156 clinical trials in ClinicalTrials.gov, 51 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Baghdad's trials are in Phase 3?
- 11 of University of Baghdad's trials are in Phase 3, spread across 16 active drug programs.
- What therapeutic areas does University of Baghdad focus on?
- University of Baghdad's most-studied conditions on ClinicalTrials.gov are Periodontitis, Periodontal Diseases, Orthodontic Appliance Complication, Plaque Induced Gingivitis, Impacted Third Molar Tooth.
- When are University of Baghdad's next clinical trial readouts?
- University of Baghdad has 10 upcoming primary-completion readouts tracked here; the soonest is “Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars”, expected around 2024-09-01.